> Pfizer ($PFE) won E.U. approval for its $16 billion Hospira ($HSP) purchase after the company agreed to sell European rights to its biosimilar version of Remicade (infliximab). Report
> Sanofi ($SNY) priced Toujeo, its new longer-acting version of Lantus, on par with the older med in the U.K. in hopes of grabbing market share to withstand generic rivals. Report
> Over the long term, birth control pills actually protect against uterine cancer, contrary to fears that they could cause the disease, a new study found. Report
> AB Science has been studying its drug candidate masitinib in a wide swath of diseases, though it has only won approval to market the drug to treat cancer in dogs. Report
And Finally... A new analysis of anti-dementia drugs such as Eisai's Aricept found that the cholinesterase inhibitors can cause harmful weight loss. Report